BayBG invests in puracon
Bayerische Beteiligungsgesellschaft (BayBG) has bought a minority stake in puracon, a supplier of packaging for medical products.
The six-figure capital injection will be used to develop a new building in Rosenheim, which will be used from September onwards and will triple puracon's production space. The fresh capital will also finance the construction of a plant in Warsaw, USA.
The Bavarian private equity house will act as a silent partner.
Company
Founded in 2003, puracon has its headquarters in Rosenheim and employs 82 staff. It provides medical packaging and logistics internationally while cleaning and sterilising the medical equipment and products of more than 200 clients worldwide.
People
Markus Krepek led the investment for BayBG. Jürgen Klein is the CEO and founder of puracon.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








